Titel

Merkliste
1 Ergebnisse

Image1_First-in-Human, Double-Blind, Randomized, Placebo-Co..:

Jingrui Liu (1694983) ; Xiaoxue Zhu (562629) ; Hong Zhang (25820)...
https://figshare.com/articles/figure/Image1_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033513. , 2021

Link: https://doi.org/10.3389/fphar.2021.689523.s001

RT Journal
T1 <Title>Image1_First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults.TIF</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_15033513&Exemplar=1&LAN=DE
				
A1 Jingrui Liu (1694983)
A1 Xiaoxue Zhu (562629)
A1 Hong Zhang (25820)
A1 Haijing Wei (9765392)
A1 Deming Yang (9538074)
A1 Zhongnan Xu (1644031)
A1 Dandan Huo (11169393)
A1 Xiaojiao Li (193668)
A1 Yanhua Ding (132997)
YR 2021
K1 Pharmacology
K1 Basic Pharmacology
K1 Clinical Pharmacology and Therapeutics
K1 Clinical Pharmacy and Pharmacy Practice
K1 Pharmaceutical Sciences
K1 Pharmacogenomics
K1 Toxicology (incl. Clinical Toxicology)
K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified
K1 TQ-F3083
K1 type 2 diabetes
K1 phase I
K1 pharmacokinetics
K1 pharmacodynamics
JF https://figshare.com/articles/figure/Image1_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033513
LK http://dx.doi.org/https://doi.org/10.3389/fphar.2021.689523.s001
DO https://doi.org/10.3389/fphar.2021.689523.s001
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)